|
CEPT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.826800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.734000E-01 |
| Normal-vs-Stage2 |
2.805800E-01 |
| Normal-vs-Stage3 |
6.081400E-01 |
| Normal-vs-Stage4 |
1.783600E-01 |
| Stage1-vs-Stage2 |
8.844300E-02 |
| Stage1-vs-Stage3 |
8.667200E-01 |
| Stage1-vs-Stage4 |
3.910800E-01 |
| Stage2-vs-Stage3 |
1.304950E-01 |
| Stage2-vs-Stage4 |
3.629500E-02 |
| Stage3-vs-Stage4 |
3.713000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.305200E-01 |
| Normal-vs-AfricanAmerican |
1.720090E-02 |
| Normal-vs-Asian |
3.865600E-01 |
| Caucasian-vs-AfricanAmerican |
5.500100E-03 |
| Caucasian-vs-Asian |
3.459400E-01 |
| AfricanAmerican-vs-Asian |
2.882200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.962200E-01 |
| Normal-vs-Female |
9.668400E-01 |
| Male-vs-Female |
2.044000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.910200E-02 |
| Normal-vs-Age(41-60Yrs) |
8.461600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.599600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.358200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.606420E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.720400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.475900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.258600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.648600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.826000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.204600E-01 |
| Normal-vs-Grade 2 |
5.548000E-01 |
| Normal-vs-Grade 3 |
2.433800E-01 |
| Normal-vs-Grade 4 |
4.374300E-02 |
| Grade 1-vs-Grade 2 |
6.519800E-01 |
| Grade 1-vs-Grade 3 |
7.301800E-01 |
| Grade 1-vs-Grade 4 |
3.319800E-01 |
| Grade 2-vs-Grade 3 |
2.211700E-02 |
| Grade 2-vs-Grade 4 |
2.404300E-03 |
| Grade 3-vs-Grade 4 |
2.040600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.809000E-01 |
| Normal-vs-ccB subtype |
1.005580E-01 |
| ccA subtype-vs-ccB subtype |
1.012880E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.498000E-01 |
| Normal-vs-N1 |
1.671800E-01 |
| N0-vs-N1 |
1.833790E-01 |
|
|
